• Home
  • Study Details
Not currently enrolling

Continuous Glucose Monitoring in T2D Basal Insulin Users: The MOBILE Study

The primary purpose of this research is to assess the benefit on glycemic control, using real time continuous glucose (CGM) versus self monitored blood glucose (SMBG/finger sticks), in persons with Type 2 Diabetes (T2D) taking basal insulin (long-acting) with or without oral medications and/or GLP-1 analogue, not at their HbA1c goal. Secondary objectives are to assess quality of life benefits of RT-CGM and to assess frequency of hypoglycemia. The Phase 2 primary objective is to determine if glycemic control worsens upon withdrawal of RT-CGM. Secondary objectives are to determine if glycemic benefits of RT-CGM use are sustainable for a long period of time (14 months), to assess QoL benefits of continuing or discontinuing RT-CGM, and to assess frequency of hypoglycemia.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female

Contact the Team


Thank you for your interest, but this study is not currently enrolling.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Laura Young

Study Topics


IRB Number


logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.